Mark Lewallyn is a Partner based in New York where he focuses on strategic advice and M&A transaction execution for healthcare services & technology companies and private equity firms. He joined Centerview in 2016 as a founding member of its market leading healthcare services and technology practice. Over the course of his career, he has advised on more than 50 transactions with aggregate transaction value of approximately $300 billion.
Representative transaction experience includes:
Payors and Value Based Care
- Express Scripts on its $67 billion sale to Cigna
- Oak Street Health on its $11 billion sale to CVS Health
- Cigna on its $3.7 billion sale of its Medicare Businesses and CareAllies to HCSC
- Landmark Health on its $3.3 billion sale to Optum
- CareBridge on its sale to Elevance Health
- HealthSun on its $2.1 billion sale to Elevance Health
- Anthem on its $1.5 billion acquisition of America’s 1st Choice
- Humana on its $725mm acquisition of Enclara Pharmacy
- InnovAge on its sale to Apax Partners
- Molina Healthcare on its terminated acquisition of NextLevel Health
Pharmacy and Supply Chain
- Blackstone, Carlyle, and H&F on their $34 billion acquisition of Medline
- Walgreens in its $24.1 billion sale to Sycamore Partners
- Comprehensive Pharmacy Solutions on its $2.8 billion sale to Optum
- Shields Health Solutions on its $2.5 billion sale to Walgreens
- Genoa Healthcare on its $2.5 billion sale to Optum
- CarepathRx Health System Solutions on its sale to Cigna
- Shields Health Solutions on its sale to Welsh Carson and Walgreens
- Pharmscript on its sale to Optum
- ExactCare on its $570mm acquisition of Tabula Rasa
Physician Services
- Cardinal Health on its $3.9 billion acquisition of GI Alliance
- Solaris Health in its $2.4 billion sale to Cardinal Health
- BioPlus on its sale to Elevance Health
- OneOncology on its $2.1 billion sale to Cencora and TPG
- EyeCare Partners on its refinancing transactions
- OneOncology on its acquisition of United Urology
- Rural Medical Group on its acquisition of Steward Medical Group
- TA Associates on its acquisition of IMA Medical Group
Pharma Services
- ICON on its $12 billion acquisition of PRA Health
- PPD on its $9.1 billion recap with Hellman & Friedman and Carlyle
- Syneos on its $7.1 billion sale to Elliott, Patient Square and Veritas
- INC Research on its $7 billion merger of equals with inVentiv Health
- inVentiv Health on its $3.7 billion sale to Advent
- Linden Capital Partners in its $2.5 billion acquisition of Klick Health
- PharmaCord on its $1.5 billion sale to Permira
- Kohlberg on its acquisition of Worldwide Clinical Trials
- UBC, a subsidiary of Express Scripts, on its sale to Avista Capital
Healthcare Technology
- MultiPlan on its $11 billion combination with Churchill Capital
- MedRisk on its sale to CVC Capital
- TransUnion RCM, a subsidiary of TransUnion, on its $1.7 billion sale to nThrive
- Kohlberg on its acquisition of Trinity Life Sciences
- Fresenius Medical in Humacyte’s $1.1 billion merger with Alpha Health
- Wellframe on its sale to Healthedge Software
- EQT on its acquisition of Certara
Before joining Centerview, Mr. Lewallyn worked in the Global Healthcare Group at Credit Suisse. Prior to pursuing a career in finance, he worked as an M&A and Capital Markets attorney in the New York office of Gibson, Dunn, & Crutcher.
He received his J.D. from the University of Virginia School of Law and his B.S. from Samford University where he was a four-year letterman on the Division 1 baseball team. He lives in Connecticut with his wife and two young children.